CELA2B
Basic information
Region (hg38): 1:15465909-15491395
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CELA2B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 11 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 4 | 1 |
Variants in CELA2B
This is a list of pathogenic ClinVar variants found in the CELA2B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-15466001-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
1-15466005-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
1-15466035-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
1-15466073-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
1-15466127-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
1-15466137-G-C | not specified | Uncertain significance (Mar 08, 2024) | ||
1-15466143-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
1-15466145-G-C | Coronary artery disorder;Diabetes;Hypertriglyceridemia;Hypertensive disorder • Abdominal obesity-metabolic syndrome 4 | Pathogenic (Oct 11, 2019) | ||
1-15467429-G-A | not specified | Likely benign (Dec 21, 2023) | ||
1-15467443-G-A | Uncertain significance (Nov 22, 2022) | |||
1-15467497-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
1-15467537-C-T | not specified | Uncertain significance (Jan 31, 2023) | ||
1-15471994-T-C | not specified | Uncertain significance (Apr 04, 2024) | ||
1-15476520-C-T | not specified | Likely benign (Oct 05, 2021) | ||
1-15481125-C-A | not specified | Likely benign (Dec 01, 2022) | ||
1-15481143-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
1-15481171-T-A | not specified | Uncertain significance (Apr 12, 2024) | ||
1-15481177-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
1-15482276-T-C | not specified | Likely benign (Nov 21, 2023) | ||
1-15482311-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
1-15482323-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
1-15482335-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
1-15483298-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
1-15485985-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
1-15486014-G-C | not specified | Uncertain significance (Nov 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CELA2B | protein_coding | protein_coding | ENST00000375910 | 8 | 25492 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000257 | 0.759 | 125532 | 1 | 214 | 125747 | 0.000855 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.430 | 183 | 167 | 1.09 | 0.0000101 | 1739 |
Missense in Polyphen | 72 | 61.311 | 1.1743 | 678 | ||
Synonymous | -1.02 | 89 | 77.5 | 1.15 | 0.00000573 | 535 |
Loss of Function | 1.23 | 11 | 16.4 | 0.672 | 8.01e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000937 | 0.000937 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00864 | 0.00863 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000158 | 0.000158 |
Middle Eastern | 0.00864 | 0.00863 |
South Asian | 0.000392 | 0.000392 |
Other | 0.000978 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Acts upon elastin.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- 0.306
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.38
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.408
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0146
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular region;extracellular space
- Molecular function
- serine-type endopeptidase activity